{"database": "lobbying", "table": "lobbying_activities", "rows": [[1582333, "53906a48-ec89-4542-a8c9-744445a6f578", "Q3", "HOLLAND & KNIGHT LLP", 18466, "ALLIANCE FOR REGENERATIVE MEDICINE", 2014, "third_quarter", "HCR", "Advocate for creation of national strategy for regenerative medicine.  Lobbied in support of legislation that would establish the national strategy, including a GAO report and federal policy coordination, which became S.2126, the Representative Medicare Promotion Act.  Also worked with White House on \"Grand Challenge.\" Also lobbied regarding H.R. 4800/S.2389, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015.  Worked with MedicalTechnology Caucus to arrange briefing.", "HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE", 50000, null, 0, 0, "2014-10-07T15:29:25.570000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1582333"], "units": {}, "query_ms": 10.687382018659264, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}